Document jyE5p3qbDyMr3DNbbaGkyJMjQ

2967874 FCM -- Chemours discussion 13.1.2021 Present: Producing polymeric substances and processing aids, which are used in packaging materials. Not in paper and board telomeric PFAS substance business. Production chain -- customers provide Chemours with specification and Chemours evaluate their products against them. On that basis Chemours consider there are no viable alternatives that provide the same combination of properties. But it is likely that if a company wants to use an alternative they would not go to the fluoropolymer supplier to ask for it. Request made for case study data including information on LCA. If there is a trade-off to be made need to understand what the consequences e.g. emissions, etc. are. Struck a chord with AW in considering whether alternatives were truly better or better only in some characteristics. Also advised to limit the number of substances they focus on in representations to MSCAs. Could talk with 5.1.2e on F-gases. TPCH Toxics and Packaging Clearing House in US -- introduced model legislation. Could be worth checking out. FP Product Group (Plastics Europe?) is preparing a RMOA for FPs -- to be ready in Q1. Asked if we can have a preview of this work. Data requests made for case study materials.